Abstract
Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disease. Crohn’s disease (CD) is among the most reported comorbid disorders in HS patients. Concurrent HS and CD are frequently associated with perianal disease that requires immunosuppressive therapy and surgery. We sought to identify unrecognized IBD associated with HS using a commercially available panel of serologic, genetic, and inflammatory markers with high specificity and sensitivity for CD (CD+) (IBD-sgi™ Panel, Prometheus Laboratories, San Diego).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
